Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cyclerion Therapeutics Inc (NQ: CYCN ) 2.540 +0.020 (+0.79%) Streaming Delayed Price Updated: 12:07 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cyclerion Therapeutics Inc < Previous 1 2 3 4 5 Next > Regina Graul, Ph.D., Promoted to Chief Executive Officer August 07, 2024 From Cyclerion Therapeutics, Inc. Via GlobeNewswire Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session July 17, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session June 21, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 21, 2024 It's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! Via InvestorPlace 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 20, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 14, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session June 13, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 12, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 22, 2024 Via Benzinga CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q1 2024 May 08, 2024 Cyclerion Therapeutics just reported results for the first quarter of 2024. Via InvestorPlace CYCN Stock Earnings: Cyclerion Therapeutics Reported Results for Q4 2023 April 05, 2024 Cyclerion Therapeutics just reported results for the fourth quarter of 2023. Via InvestorPlace 12 Health Care Stocks Moving In Tuesday's Intraday Session February 06, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session January 11, 2024 Via Benzinga Cyclerion Appoints Regina Graul, Ph.D., as President December 04, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Intraday Session December 01, 2023 Via Benzinga Why Genesco Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session December 01, 2023 Gainers Harbor Custom Development, Inc. (NASDAQ: HCDI) rose 74.2% to $1.50 after surging 24% on Thursday. Via Benzinga Cyclerion Strengthens Board of Directors with Experienced Company Builder and Cutting-edge Innovator November 30, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session October 10, 2023 Via Benzinga Tisento Launches with $81 Million From Top-Tier Investor Syndicate and Promising Cyclerion Assets July 31, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday July 27, 2023 During Thursday, 56 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Tuesday July 25, 2023 On Tuesday, 56 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Wednesday July 26, 2023 Wednesday saw 59 companies set new 52-week lows. Via Benzinga Cyclerion Regains Compliance with Nasdaq Minimum Bid Price Requirement June 01, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire Why RH Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session May 16, 2023 Gainers GD Culture Group Limited (NASDAQ: GDC) shares climbed 121.9% to $9.63 after gaining over 8% on Monday. GD Culture recently announced an $11.55 million registered direct offering. Via Benzinga Cyclerion Announces Reverse Stock Split May 15, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire Cyclerion Therapeutics to Sell Assets for $81M, CEO Transition To New Spin-Off Private Company Established By Shareholders, New Investors May 12, 2023 Cyclerion Therapeutics Inc (NASDAQ: CYCN) has agreed to sell two of its assets - zagociguat (formerly CY6463) and CY3018, to a new private company ("NewCo") formed by certain current Cyclerion... Via Benzinga Cyclerion Announces Corporate Updates and Q1 2023 Financial Results May 11, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire Cyclerion Announces Definitive Agreement for Zagociguat and CY3018 May 11, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 26, 2023 Via Benzinga Cyclerion Therapeutics Enters into Exclusive Negotiation Period and Binding Equity Investment Agreement April 03, 2023 From Cyclerion Therapeutics, Inc. Via GlobeNewswire < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.